Of the moderate events, 9 cases of “COVID-19” in 9 subjects were determined to be “unlikely related” to the study drug, while the other 6 cases in 3 subjects were considered “possibly related.” These included incidents of sensory reduction, elevated aspartate aminotransferase, anemia, elevated alanine aminotransferase, upper respiratory tract infection, and muscle spasms, each occurring once. This evidence concerns the gene GPT and anemia.